JMP Securities maintains AN2 Therapeutics stock with $5 target
JMP Securities reiterated its Market Outperform rating on AN2 Therapeutics (NASDAQ:ANTX) shares, maintaining a $5.00 price target, representing significant upside from the current price of $1.14.
JMP maintains Unity Software stock at Market Perform
JMP Securities maintained its Market Perform rating on Unity Software (NYSE:U), reflecting a cautious yet stable outlook for the company. Analysts at JMP Securities have not modified their price ...
JMP Securities Reaffirms Their Buy Rating on GH Research (GHRS)
In a report released today, Jason Butler from JMP Securities reiterated a Buy rating on GH Research (GHRS – Research Report), with a price ...
JMP Securities Reaffirms Their Buy Rating on Roku (ROKU)
In a report released today, Matthew Condon from JMP Securities reiterated a Buy rating on Roku (ROKU – Research Report), with a price target of ...
Why Pharvaris (PHVS) Is Advancing Today
Pharvaris (PHVS) is climbing 3% after investment bank JMP Securities raised its price target on the shares to $55, based on ...
Cloudflare, CyberArk see price targets raised at JMP ahead of earnings
JMP Securities raised the price targets on Cloudflare (NET) and CyberArk Software (CYBR), while highlighting an industry ...
Cloudflare, Inc. (NET) Gets Price Target Upgrades from JMP and Truist Ahead of Q4 Earnings
In this article, we are going to take a look at where Cloudflare, Inc. (NYSE:NET) stands against the other AI stocks. AI is ...
Option Care Health price target raised to $35 from $30 at JMP Securities
JMP Securities analyst Constantine Davides raised the firm’s price target on Option Care Health (OPCH) to $35 from $30 and ...
Yahoo Finance25d
JMP Expects a ‘Value-Creating Year’ for These 2 High-Yield Dividend Stocks
Covering some solid dividend stocks for JMP, analyst Aaron Hecht sees a reason to bet on higher value in the coming year. He notes that multiple tailwinds are coming together, and will likely lead ...